Status: Recruiting
A Study Intravitreal THN391 in Diabetic Macular Oedema Secondary to Non-Proliferative Diabetic Retinopathy.
THN391-OPT-101 is a study assessing safety and preliminary efficacy of THN391 in patients with diabetic macular edema (DME) given as monotherapy.
Participants needed: 21
Trial details
Phase: Phase 1Age: 18-80Biological sex: AllType: InterventionalSponsor: Therini Bio Pty LtdUpdated: Jul 2, 2026Locations: 7
Eligibility criteria
Be willing and able to understand the study procedures and the risks involved an... [+3]
Be pregnant or breastfeeding [+2]